HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival

被引:57
作者
Menier, C
Riteau, B
Dausset, J
Carosella, ED
Rouas-Freiss, N [1 ]
机构
[1] Hop St Louis, IUH, CEA, DSV,DRM,Serv Rech Hemato Immunol, F-75010 Paris, France
[2] Fdn Jean Dausset, Paris 10, France
关键词
HLA-G isoforms; NK cells; pregnancy; tolerance; trophoblast;
D O I
10.1016/S0198-8859(00)00194-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pregnancy is considered as an immunologic paradox because the fetus can be viewed as a semi-allograft by the mother's immune system. Among the different: factors implicated in the maternal-fetal tolerance, a central role has been attributed to HLA-G. The primary HLA-G mRNA is alternatively spliced, encoding four membrane-bound isoforms (HLA-G1, -G2, -G3, and -G4), and three soluble forms (HLA-GS, -G6, and -G7). Whereas HLA-G1 is expressed on trophoblast cells, HLA-G2,-G3, and -G4 isoforms have been only identified as transcripts in trophoblast and term placentas. In this work, we-first showed that these HLA-G transcripts are translated inco proteins in first trimester cytotrophoblast cells. Then, using a target cell line transfected with HLA-G genomic DNA, me analyzed the Functional implication of HLA-G isoforms expression on NK function. Our results show that not only HLA-G1, but also the other HLA-G truncated isoforms, can inhibit NK cytolysis and therefore contribute to immune privilege for the fetus. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:1118 / 1125
页数:8
相关论文
共 34 条
[1]   A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation [J].
Aldrich, C ;
Verp, MS ;
Walker, MA ;
Ober, C .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 47 (01) :41-48
[2]  
Avril T, 1999, J IMMUNOL, V162, P5902
[3]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[4]   HLA-G revisited [J].
Carosella, ED ;
Dausset, J ;
Kirszenbaum, M .
IMMUNOLOGY TODAY, 1996, 17 (09) :407-409
[5]   IN-SITU HYBRIDIZATION AND NORTHERN BLOT DEMONSTRATION OF HLA-G MESSENGER-RNA IN HUMAN TROPHOBLAST POPULATIONS BY LOCUS-SPECIFIC OLIGONUCLEOTIDE [J].
CHUMBLEY, G ;
KING, A ;
HOLMES, N ;
LOKE, YW .
HUMAN IMMUNOLOGY, 1993, 37 (01) :17-22
[6]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[7]   A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules [J].
Cosman, D ;
Fanger, N ;
Borges, L ;
Kubin, M ;
Chin, W ;
Peterson, L ;
Hsu, ML .
IMMUNITY, 1997, 7 (02) :273-282
[8]   Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts [J].
Crisa, L ;
McMaster, MT ;
Ishii, JK ;
Fisher, SJ ;
Salomon, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :289-298
[9]   HOMOZYGOUS HUMAN TAP PEPTIDE TRANSPORTER MUTATION IN HLA CLASS-I DEFICIENCY [J].
DELASALLE, H ;
HANAU, D ;
FRICKER, D ;
URLACHER, A ;
KELLY, A ;
SALAMERO, J ;
POWIS, SH ;
DONATO, L ;
BAUSINGER, H ;
LAFORET, M ;
JERAS, M ;
SPEHNER, D ;
BIEBER, T ;
FALKENRODT, A ;
CAZENAVE, JP ;
TROWSDALE, J ;
TONGIO, MM .
SCIENCE, 1994, 265 (5169) :237-241
[10]  
FUJII T, 1994, J IMMUNOL, V153, P5516